Afuco™ Anti-B. anthracis PA ADCC Therapeutic Antibody (Raxibacumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Bacillus anthracis protective antigen. Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-224 |
| Pricing | Inquiry |
| Host | Human |
| Target | B. anthracis PA |
| Species Reactivity | B. anthracis |
| Type | ADCC enhanced antibody |
| Applications | FC, IP, ELISA, Neut, FuncS, IF |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |